ALNOX.PA Gross Margin

The Gross Margin of Noxxon Pharma NV (ALNOX.PA) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ALNOX.PA Gross Margin - Peers Comparison

Ticker	Name	Value
ALPRE.PA	Predilife SA	97.25%
CVAC	CureVac NV	80.23%
MOR.DE	MorphoSys AG	78.62%
VAL.L	ValiRx PLC	85.00%
XINT.ST	Xintela AB	100.00%
IMMU.ST	Mendus AB (publ)	7775.20%
SCS.WA	Stem Cells Spin SA	86.16%
AEGIR.ST	Aegirbio AB	47.83%
ALLR.ST	Allarity Therapeutics A/S	-175.91%
BNTX	Biontech SE	84.90%
GEN.WA	Genomed SA	44.96%
ABNX.PA	Abionyx Pharma SA	18.35%
HPHA.DE	Heidelberg Pharma AG	74.01%
IDOGEN.ST	Idogen AB	7775.20%
LIDDS.ST	Lidds AB	-1102.81%
GV.PA	Genomic Vision SA	-165.01%
SENZA.ST	SenzaGen AB	66.89%
AFMD	Affimed NV	83.70%
ALPAT.PA	Plant Advanced Technologies PAT SA	128.03%
MTPH.L	Midatech Pharma PLC	94.91%
ATORX.ST	Alligator Bioscience AB	-312.94%
COMBI.ST	Combigene AB	-14.34%
EVG.L	Evgen Pharma PLC	-1151.58%
FYB.DE	Formycon AG	20.25%
GUARD.ST	Guard Therapeutics International AB (publ)	100.00%
SPRINT.ST	Sprint Bioscience AB	56.83%
ACTI.ST	Active Biotech AB publ	100.00%
BIO.DE	Biotest AG	30.82%
CNTG	Centogene NV	36.46%
ISR.ST	ISR Immune System Regulation Holding AB (publ)	-45046.17%
MVIR B.ST	Medivir AB	-147045.00%
RDG.WA	Read Gene SA	93.23%
VVY.AS	Vivoryon Therapeutics NV	85.42%
ALNEV.PA	Neovacs SA	5.49%
ALZ.ST	Alzinova AB	-32846.67%
IMTX	Immatics NV	7775.20%
PROMO.ST	Promore Pharma AB	-124472.22%